RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Jesus A. Angulo to Male

This is a "connection" page, showing publications Jesus A. Angulo has written about Male.
Connection Strength

0.568
  1. Pan AL, Hasalliu E, Hasalliu M, Angulo JA. Epigallocatechin Gallate Mitigates the Methamphetamine-Induced Striatal Dopamine Terminal Toxicity by Preventing Oxidative Stress in the Mouse Brain. Neurotox Res. 2020 Apr; 37(4):883-892.
    View in: PubMed
    Score: 0.047
  2. Liu Q, Hazan A, Grinman E, Angulo JA. Pharmacological activation of the neurotensin receptor 1 abrogates the methamphetamine-induced striatal apoptosis in the mouse brain. Brain Res. 2017 03 15; 1659:148-155.
    View in: PubMed
    Score: 0.038
  3. Tulloch IK, Afanador L, Baker L, Ordonez D, Payne H, Mexhitaj I, Olivares E, Chowdhury A, Angulo JA. Methamphetamine induces low levels of neurogenesis in striatal neuron subpopulations and differential motor performance. Neurotox Res. 2014 Aug; 26(2):115-29.
    View in: PubMed
    Score: 0.031
  4. Afanador L, Mexhitaj I, Diaz C, Ordonez D, Baker L, Angulo JA. The role of the neuropeptide somatostatin on methamphetamine and glutamate-induced neurotoxicity in the striatum of mice. Brain Res. 2013 May 13; 1510:38-47.
    View in: PubMed
    Score: 0.029
  5. Yarosh HL, Angulo JA. Modulation of methamphetamine-induced nitric oxide production by neuropeptide Y in the murine striatum. Brain Res. 2012 Nov 05; 1483:31-8.
    View in: PubMed
    Score: 0.028
  6. Tulloch I, Afanador L, Mexhitaj I, Ghazaryan N, Garzagongora AG, Angulo JA. A single high dose of methamphetamine induces apoptotic and necrotic striatal cell loss lasting up to 3 months in mice. Neuroscience. 2011 Oct 13; 193:162-9.
    View in: PubMed
    Score: 0.026
  7. Tulloch I, Ghazaryan N, Mexhitaj I, Ordonez D, Angulo JA. Role of neurokinin-1 and dopamine receptors on the striatal methamphetamine-induced proliferation of new cells in mice. Brain Res. 2011 Jul 05; 1399:33-9.
    View in: PubMed
    Score: 0.026
  8. Wang J, Angulo JA. Synergism between methamphetamine and the neuropeptide substance P on the production of nitric oxide in the striatum of mice. Brain Res. 2011 Jan 19; 1369:131-9.
    View in: PubMed
    Score: 0.025
  9. Wang J, Angulo JA. Methamphetamine induces striatal neurokinin-1 receptor endocytosis primarily in somatostatin/NPY/NOS interneurons and the role of dopamine receptors in mice. Synapse. 2011 Apr; 65(4):300-8.
    View in: PubMed
    Score: 0.025
  10. Zhu J, Xu W, Wang J, Ali SF, Angulo JA. The neurokinin-1 receptor modulates the methamphetamine-induced striatal apoptosis and nitric oxide formation in mice. J Neurochem. 2009 Nov; 111(3):656-68.
    View in: PubMed
    Score: 0.023
  11. Wang J, Xu W, Ali SF, Angulo JA. Connection between the striatal neurokinin-1 receptor and nitric oxide formation during methamphetamine exposure. Ann N Y Acad Sci. 2008 Oct; 1139:164-71.
    View in: PubMed
    Score: 0.021
  12. Zhu JP, Xu W, Angulo JA. Distinct mechanisms mediating methamphetamine-induced neuronal apoptosis and dopamine terminal damage share the neuropeptide substance p in the striatum of mice. Ann N Y Acad Sci. 2006 Aug; 1074:135-48.
    View in: PubMed
    Score: 0.018
  13. Zhu JP, Xu W, Angulo JA. Methamphetamine-induced cell death: selective vulnerability in neuronal subpopulations of the striatum in mice. Neuroscience. 2006 Jun 30; 140(2):607-22.
    View in: PubMed
    Score: 0.018
  14. Zhu JP, Xu W, Angulo N, Angulo JA. Methamphetamine-induced striatal apoptosis in the mouse brain: comparison of a binge to an acute bolus drug administration. Neurotoxicology. 2006 Jan; 27(1):131-6.
    View in: PubMed
    Score: 0.017
  15. Zhu JP, Xu W, Angulo JA. Disparity in the temporal appearance of methamphetamine-induced apoptosis and depletion of dopamine terminal markers in the striatum of mice. Brain Res. 2005 Jul 12; 1049(2):171-81.
    View in: PubMed
    Score: 0.017
  16. Angulo JA, Angulo N, Yu J. Antagonists of the neurokinin-1 or dopamine D1 receptors confer protection from methamphetamine on dopamine terminals of the mouse striatum. Ann N Y Acad Sci. 2004 Oct; 1025:171-80.
    View in: PubMed
    Score: 0.016
  17. Yu J, Wang J, Cadet JL, Angulo JA. Histological evidence supporting a role for the striatal neurokinin-1 receptor in methamphetamine-induced neurotoxicity in the mouse brain. Brain Res. 2004 May 08; 1007(1-2):124-31.
    View in: PubMed
    Score: 0.016
  18. Yu J, Cadet JL, Angulo JA. Neurokinin-1 (NK-1) receptor antagonists abrogate methamphetamine-induced striatal dopaminergic neurotoxicity in the murine brain. J Neurochem. 2002 Nov; 83(3):613-22.
    View in: PubMed
    Score: 0.014
  19. Yu J, Allison S, Ibrahim D, Cadet JL, Angulo JA. Ontogeny of neurokinin-1 receptor mediation of methamphetamine neurotoxicity in the striatum of the mouse brain. Ann N Y Acad Sci. 2002 Jun; 965:247-53.
    View in: PubMed
    Score: 0.014
  20. Noailles PA, Angulo JA. Neurokinin receptors modulate the neurochemical actions of cocaine. Ann N Y Acad Sci. 2002 Jun; 965:267-73.
    View in: PubMed
    Score: 0.014
  21. Kraft M, Noailles P, Angulo JA. Substance P modulates cocaine-evoked dopamine overflow in the striatum of the rat brain. Ann N Y Acad Sci. 2001 Jun; 937:121-31.
    View in: PubMed
    Score: 0.013
  22. Kraft M, Ahluwahlia S, Angulo JA. Neurokinin-1 receptor antagonists block acute cocaine-induced horizontal locomotion. Ann N Y Acad Sci. 2001 Jun; 937:132-9.
    View in: PubMed
    Score: 0.013
  23. Zhang Y, Loonam TM, Noailles PA, Angulo JA. Comparison of cocaine- and methamphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions. Ann N Y Acad Sci. 2001 Jun; 937:93-120.
    View in: PubMed
    Score: 0.013
  24. Datta U, Noailles PA, Kraft M, Zhang Y, Angulo JA. Concurrent elevation of the levels of expression of striatal preproenkephalin and preprodynorphin mRNA in the rat brain by chronic treatment with caffeine. Neurosci Lett. 1997 Aug 01; 231(1):29-32.
    View in: PubMed
    Score: 0.010
  25. Zhang Y, Landas K, Mueller H, Angulo JA. Progressive augmentation of striatal and accumbal preprotachykinin mRNA levels by chronic treatment with methamphetamine and effect of concurrent administration of the N-methyl-D-aspartate receptor antagonist MK-801. Neuropharmacology. 1997 Mar; 36(3):325-34.
    View in: PubMed
    Score: 0.010
  26. Datta U, Noailles PA, Rodriguez M, Kraft M, Zhang Y, Angulo JA. Accumulation of tyrosine hydroxylase messenger RNA molecules in the rat mesencephalon by chronic caffeine treatment. Neurosci Lett. 1996 Dec 13; 220(2):77-80.
    View in: PubMed
    Score: 0.009
  27. Zhang Y, Angulo JA. Contrasting effects of repeated treatment vs. withdrawal of methamphetamine on tyrosine hydroxylase messenger RNA levels in the ventral tegmental area and substantia nigra zona compacta of the rat brain. Synapse. 1996 Nov; 24(3):218-23.
    View in: PubMed
    Score: 0.009
  28. Noailles PA, Villegas M, Ledoux M, Lucas LR, McEwen BS, Angulo JA. Acute treatment with the N-methyl-D-aspartate receptor antagonist MK-801: effect of concurrent administration of haloperidol or scopolamine on preproenkephalin mRNA levels of the striatum and nucleus accumbens of the rat brain. Neurosci Lett. 1996 Jan 05; 202(3):165-68.
    View in: PubMed
    Score: 0.009
  29. Villegas M, Angulo JA. Attenuation of neostriatal preproenkephalin and preprotachykinin mRNA abundance by chronic treatment with the kainate/quisqualate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione in the rat brain. Neurosci Lett. 1995 May 19; 191(1-2):51-4.
    View in: PubMed
    Score: 0.009
  30. Angulo JA, Williams A, Ledoux M, Watanabe Y, McEwen BS. Elevation of striatal and accumbal preproenkephalin, preprotachykinin and preprodynorphin mRNA abundance subsequent to N-methyl-D-aspartate receptor blockade with MK-801. Brain Res Mol Brain Res. 1995 Mar; 29(1):15-22.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support